SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-22-084389
Filing Date
2022-08-01
Accepted
2022-08-01 06:01:13
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm2222219d1_8k.htm DEFA14A 34620
2 EXHIBIT 3.1 tm2222219d1_ex3-1.htm EX-3.1 91815
3 EXHIBIT 3.2 tm2222219d1_ex3-2.htm EX-3.2 92432
4 EXHIBIT 10.1 tm2222219d1_ex10-1.htm EX-10.1 196649
5 EXHIBIT 99.1 tm2222219d1_ex99-1.htm EX-99.1 13920
  Complete submission text file 0001104659-22-084389.txt   430757
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12584 | Film No.: 221122641
SIC: 2834 Pharmaceutical Preparations